In 2004, Sanofi-Synthélabo offered a takeover bid worth €47.8 billion for Aventis. After a number of deliberations, over a period of three months, Aventis agreed to an offer of €54.5 billion ...

Sanofi India Limited, was initially incorporated as Aventis Pharma Limited in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.

Sanofi shares were down 1.2% as of 0750 GMT, at 86.53 euros a share. For more insights like these, click here , opens new tab to try Breakingviews for free. Suggested Topics: ...

Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. Itepekimab, a medicine that is being jointly developed by Sanofi and Regeneron, is being tested ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a European ...

PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck ...

The cover art for 1Type's first single. (Sanofi) The song also features a spoken word interlude by Duke Al Durham, a U.K.-based poet and hip-hop artist who also has Type 1 diabetes.

French pharmaceutical giant Sanofi is set to acquire U.S.-based Blueprint Medicines Corporation in a deal worth up to $9.5 billion, marking one of the largest European healthcare transactions of ...

Sanofi has been active in the M&A market this year, picking up Dren Bio’s clinical-stage bispecific antibody, DR-0201, for $600 million upfront and another $1.3 billion in milestones. Last month ...

Sanofi SAN-0.71 % decrease; red down pointing triangle agreed to buy Blueprint Medicines BPMC-0.05 % decrease; red down pointing triangle for up to $9.5 billion, the French drugmaker’s biggest ...

Sanofi shares on Euronext Paris, however, dipped 1.8% from €87.52 ($99.85) to €85.91 ($98.18). Hudson also said that Sanofi still retained a “sizeable” capacity for further acquisitions.